Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Corrigendum to "Efficacy and safety of basal insulin degludec 100 IU/mL versus glargine 300 IU/mL for type 1 diabetes: The single-center INEOX randomized controlled trial" [Diabetes Res. Clin. Pract. 196 (2023) 110238].
Ruiz-de-Adana MS, Domínguez ME, Morillas V, Colomo N, Vallejo-Mora R, Guerrero M, García-Escobar E, Carreira M, Romero-Zerbo Y, Linares F, González-Mariscal I, Bermúdez-Silva FJ, Olveira G, Rojo-Martínez G. Ruiz-de-Adana MS, et al. Among authors: morillas v. Diabetes Res Clin Pract. 2024 Apr;210:111620. doi: 10.1016/j.diabres.2024.111620. Epub 2024 Mar 21. Diabetes Res Clin Pract. 2024. PMID: 38514300 No abstract available.
Efficacy and safety of basal insulin degludec 100 IU/mL versus glargine 300 IU/mL for type 1 diabetes: The single-center INEOX randomized controlled trial.
Ruiz de Adana MS, Domínguez ME, Morillas V, Colomo N, Vallejo-Mora R, Guerrero M, García-Escobar E, Carreira M, Romero-Zerbo Y, Linares F, González-Mariscal I, Bermúdez-Silva FJ, Olveira G, Rojo-Martínez G. Ruiz de Adana MS, et al. Among authors: morillas v. Diabetes Res Clin Pract. 2023 Feb;196:110238. doi: 10.1016/j.diabres.2023.110238. Epub 2023 Jan 5. Diabetes Res Clin Pract. 2023. PMID: 36610544 Clinical Trial.
Patients with primary cutaneous lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry.
Sánchez-Velázquez A, Bauer-Alonso A, Estrach T, Vega-Díez D, Garcia-Muret P, Haya L, Peñate Y, Acebo E, Fernández de Misa R, Blanes M, Suh-Oh HJ, Izu R, Silva-Díaz E, Sarriugarte J, Román-Curto C, Botella-Estrada R, Mateu-Puchades A, Prieto-Torres L, Morillas V, Morillo M, Sánchez-Caminero P, Calzado L, Pérez-Ferriols A, Pérez A, Domínguez JD, Navedo M, Muniesa C, Combalia A, Arroyo-Andrés J, Descalzo MA, García-Doval I, Ortiz-Romero PL. Sánchez-Velázquez A, et al. Among authors: morillas v. J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e624-e626. doi: 10.1111/jdv.17430. Epub 2021 Jul 2. J Eur Acad Dermatol Venereol. 2021. PMID: 34062018 Free PMC article. No abstract available.
Bowel-associated dermatosis-arthritis syndrome (BADAS).
Richarz NA, Bielsa I, Morillas V, Enguita V, Fumagalli C. Richarz NA, et al. Among authors: morillas v. Australas J Dermatol. 2021 May;62(2):241-242. doi: 10.1111/ajd.13516. Epub 2020 Dec 12. Australas J Dermatol. 2021. PMID: 33314024 No abstract available.
Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19).
Carrascosa JM, Morillas V, Bielsa I, Munera-Campos M. Carrascosa JM, et al. Among authors: morillas v. Actas Dermosifiliogr (Engl Ed). 2020 Nov;111(9):734-742. doi: 10.1016/j.ad.2020.08.002. Epub 2020 Aug 31. Actas Dermosifiliogr (Engl Ed). 2020. PMID: 32882184 Free PMC article. Review. English, Spanish.